Research in allergic diseases diagnosis and treatment

SCIENTIFIC PRODUCTION PRIOR TO DECEMBER 2019 IS LINKED TO THE GROUP "EPIDEMIOLOGY AND CLINICAL BIOSTATISTICS"

Group leader

Belén de la Hoz Caballer

alergiaramonycajal(ELIMINAR)@gmail.com

913368340 / 913368864

Principal Investigator

  • Maria Pilar Berges Gimeno

Collaborating Staff

  • Lorena Bernal Rubio
  • María Pia de Calzada Bustingorri
  • David González de Olano
  • Francisco Javier Sola Martínez
  • Emilio José Solano Solares
  • Soledad Terrados Cepeda
  • Carmen Vidal Albareda
  • Alicia Barra Castro
  • Ana de Andrés Martín
  • Cristina Pueyo Lopez
  • Darío Antolín Amérigo
  • Cristiana Lucia Solorzano Zepeda
  • Violeta Sánchez García
  • Sergio Olmos Piñero
  • Laura Gisella Diaz Montalvo
Imagen equipo

Group leader

Belén de la Hoz Caballer

alergiaramonycajal(ELIMINAR)@gmail.com

913368340 / 913368864

Principal Investigator

  • Maria Pilar Berges Gimeno

Collaborating Staff

  • Lorena Bernal Rubio
  • María Pia de Calzada Bustingorri
  • David González de Olano
  • Francisco Javier Sola Martínez
  • Emilio José Solano Solares
  • Soledad Terrados Cepeda
  • Carmen Vidal Albareda
  • Alicia Barra Castro
  • Ana de Andrés Martín
  • Cristina Pueyo Lopez
  • Darío Antolín Amérigo
  • Cristiana Lucia Solorzano Zepeda
  • Violeta Sánchez García
  • Sergio Olmos Piñero
  • Laura Gisella Diaz Montalvo

STRATEGIC OBJECTIVES

  • Search for biomarkers, based on B cell epitopes and microRNA expression, to improve the diagnosis and treatment of food allergy.
  • To measure the quality of life and socioeconomic costs associated with food allergy.
  • To develop technological instruments for monitoring food allergy in patients undergoing immunotherapy. 
  • To assess the usefulness of the “in vitro” techniques of basophils activation and interleukins determination for the diagnosis and monitoring of desensitization treatment with chemotherapeutic agents and biological drugs. 
  • To assess the quality of life and associated costs of drug desensitization procedures. 
  • To assess the frequency of mast cell disease in patients with anaphylaxis.
  • To assess risk factors for severe asthma.
  • Technological and clinical validation of a respiratory exposure chamber against aeroallergens.Validación tecnológica y clínica de una cámara de exposición respiratoria frente a aeroalérgenos.

RESEARCH LINES

  • Diagnosis and treatment of food allergy. 
  • Diagnosis and treatment of allergy to chemotherapeutic and biological drugs.
  • Anaphylaxis and mastocytosis.
  • Respiratory allergy.

Location

Ramón y Cajal University Hospital

Allergy Department (2nd floor)  

Keywords

Allergy, biomarkers, food allergy, B epitopes, asthma, allergen exposure, immunotherapy, desensitization, drug allergy, quality of life, pharmacoeconomy.